OCSL Slashes Distribution as NAV Erodes and Credit Losses Deepen
OCSL is trading near its 52-week low of $10.63 (12% above the low).
Summary
OCSL's fiscal Q3 brought a dip in NII per share, a declining NAV, and a 25% distribution cut amid mounting credit losses. A wide discount to NAV further limits capital-raising options.
Key Events · Earnings and Guidance · OCSL
-
Distribution Cut
The quarterly distribution was reduced by 25% to $0.30 per share from $0.40, alongside a $0.04 supplemental. The board pointed to lower earnings and a goal of aligning payouts with taxable income.
-
NAV Decline
Net asset value per share fell to $15.70 from $16.64 at September 30, 2025, pressured by net realized and unrealized losses on investments.
-
Credit Deterioration
Six portfolio companies are on non-accrual status, representing 4.2% of debt investments at cost. Net realized losses for the quarter reached $49.5 million, driven primarily by Dominion Diagnostics, Mosaic Companies, and Spanx.
-
Earnings Pressure
Net investment income per share came in at $0.37, down from $0.38 a year ago, as lower reference rates weighed on interest income. Total investment income declined 7.8% year-over-year.
Analysis · OCSL · Unknown
A challenging quarter unfolded for Oaktree Specialty Lending. Net investment income per share edged down to $0.37 from $0.38 a year ago, while net asset value dropped to $15.70 from $16.64 at fiscal year-end. Reflecting caution around earnings power, the board cut the quarterly distribution by 25% to $0.30 from $0.40. Credit quality worsened materially: six investments are now on non-accrual, and the company absorbed $49.5 million in net realized losses, largely tied to Dominion Diagnostics, Mosaic, and Spanx. With the stock trading at a steep discount to NAV, equity issuance is constrained, forcing greater reliance on portfolio cash flows to fund the dividend.
At the time of this filing, OCSL was trading at $11.93 on NASDAQ in the Unknown sector, with a market capitalization of approximately $1.1B. The 52-week trading range was $10.63 to $14.31. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.